Investor Presentations
Advaxis’ senior management team hosted an Analyst and Investor Day featuring an overview of its proprietary technology platform, clinical and corporate milestones for 2015 and evidence-based scientific presentations from principal investigators leading the company’s Lm-LLO immunotherapy cross-tumor preclinical and clinical study programs.
The full webcast and presentation slides from the Analyst and Investor Day can be accessed via https://www.advaxiscompany.xyz/advaxis-analyst-investor-day.
Precise goals of the event were two-fold:
- To offer an open opportunity to interact with physicians actively working with the Advaxis immunotherapy technology; and
- To provide a transparent understanding of company scientific and clinical goals in 2015 and beyond.
Key highlights from each Analyst and Investor Day speaker are summarized below: